Bladder Carcinoma clinical trials
Showing 101–150 of 153 active trials. Describe your situation to see which ones look like a fit.
- Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Urologic Lymphadenectomy in AMIGO
- Evaluation for NCI Surgery Branch Clinical Research Protocols
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
- DESTINY-PANTUMOUR04
- Pan-tumor MRD Study
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Integrated Cancer Repository for Cancer Research
- An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
- Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
- Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
- Patient-Centered Surgical Prehabilitation
- A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
- Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- Telehealth Intervention for Ostomy Self-Management
- Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
- Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
- A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- Distance-Based Exercise to Preserve Function and Prevent Disability
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Vaginal Dilator Therapy After Pelvic Radiation
- Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Improving Care for Rural Patients With Solid Tumors
- Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
- Better Options for Chronic Cancer Pain
- VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors
- Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
- Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
- STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy
- Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
- Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
- Use of Wearables Following Cystectomy- Part II
- Clinical Trial to Treat Stage IV Cancer Patients
- Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
- Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer
- Intravesical Gem/Doce in Patients With NMIBC
- A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
- Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.